Seegene

20/11/2025

Accurate bacterial detection can make a critical difference in patient outcomes.
Bacterial infections account for nearly 60% of infectious disease complications, yet many are initially mistaken for viral infections — delaying timely and appropriate care.

At Seegene, we deliver high-multiplex molecular diagnostics that enable clinicians to confidently identify bacterial pathogens and make timely, evidence-based decisions in patient care.

06/11/2025

🔗 Read the full story on Nature: https://www.nature.com/articles/d42473-025-00313-5

We’re pleased to share our latest Nature feature exploring how advances in PCR-based HPV testing can make a meaningful impact on women’s health, particularly in the early detection and prevention of cervical cancer. Read to see how Seegene’s high-multiplex HPV genotyping and efforts toward total lab automation help clinicians in different regions enhance cervical cancer screening.

※ Branded content published in collaboration with Springer Nature

Advances in PCR testing could make a major impact on women’s health, especially in the diagnosis and treatment of cervical cancer.

04/11/2025

We were honored to join the LMCE & KSLM 2025, one of the world’s leading congresses in laboratory medicine, bringing together global experts, clinicians, and innovators.

At the Seegene booth, visitors explored ™, our fully automated PCR testing system, showcased in a miniature display to demonstrate its end-to-end automation from sample loading to result analysis across various sample types. We also featured a hands-on ™ experience zone, where participants could explore our real-time diagnostic data analysis and sharing platform.

We sincerely thank everyone who visited our booth and symposium. Your engagement made LMCE 2025 a truly inspiring experience in advancing diagnostic excellence together.

04/11/2025

We were honored to join the LMCE & KSLM 2025, one of the world’s leading congresses in laboratory medicine, bringing together global experts, clinicians, and innovators.

At the Seegene booth, visitors explored ™, our fully automated PCR testing system, showcased in a miniature display to demonstrate its end-to-end automation from sample loading to result analysis across various sample types. We also featured a hands-on STAgora™ experience zone, where participants could explore our real-time diagnostic data analysis and sharing platform.

We sincerely thank everyone who visited our booth and symposium. Your engagement made LMCE 2025 a truly inspiring experience in advancing diagnostic excellence together.

27/10/2025

Remember: The real threat isn’t what you see.
Viruses may steal the spotlight with their rapid spread, but it’s often bacteria working behind the scenes—causing the most serious complications.
That’s why precise detection and monitoring of both are crucial

27/10/2025

Viruses often steal the spotlight with their rapid spread and visible symptoms. Yet, it’s the bacteria behind the scenes that frequently cause the most serious complications.

That’s why precise detection and continuous monitoring of both are essential, ensuring timely treatment and better patient outcomes.

16/10/2025

🔗 Read the full story on Nature: https://bit.ly/3Jog5PK

We’re pleased to share our latest Nature feature introducing how the Nature Awards MDx Impact Grants, offered by Springer Nature in partnership with Seegene, are helping reduce the risk of infectious diseases for current and future generations.

From detecting antibiotic-resistant Klebsiella pneumoniae to developing tests for viruses in immunocompromised patients, the 2024–2025 grant-winning projects highlight the transformative potential of molecular diagnostics in protecting vulnerable populations worldwide.

※ Branded content published in collaboration with Springer Nature

New multiplex PCR diagnostic techniques aim to curb the rising tide of antibiotic-resistant microbes and optimize the treatment of diverse patient groups.

30/09/2025

Seegene is excited to join 2025 & the 66th Annual Meeting!

Visit us at Booth -02 and explore how our advanced PCR technologies are shaping the future of molecular diagnostics.
Let’s connect in Incheon!

📅 October 29-31, 2025
📍 Inspire Convention Center, Incheon, Korea

We look forward to meaningful exchanges with colleagues in laboratory medicine from around the world.

26/09/2025

Most viruses once followed predictable seasonal cycles. But since the COVID-19 pandemic, infection patterns have become increasingly unpredictable, with respiratory outbreaks occurring beyond their usual seasons.

This shift has made clinical diagnostics and treatment strategies far more complex, demanding a more flexible and forward-looking approach to infectious disease surveillance and management.

At Seegene, we are committed to enabling healthcare professionals worldwide to stay ahead with precise and reliable molecular diagnostic solutions.

👉 Learn more about our respiratory diagnostic solutions: https://bit.ly/3VxfjTb

23/09/2025

Seegene invites you to our Symposium at & 2025!

📅 Thursday, October 30
🕛 12:00–13:00
📍 Room E (EW 08), Inspire Convention Center, Incheon

Join us to explore the latest advances in molecular diagnostics and engage with experts shaping the future of laboratory medicine.

15/09/2025

🎉Today marks Seegene’s 25th !

For 25 years, has walked its own path in molecular diagnostics and turned challenges once thought impossible into reality. These achievements have become part of our DNA, made possible by the dedication and passion of our people.

With unrivaled expertise and a relentless commitment to innovation, we will continue to redefine the future of molecular diagnostics to move closer to our vision of a world free from all diseases.

12/09/2025

Syndromic testing enables clinicians to identify pathogens in one go, even when symptoms overlap.

Especially effective for respiratory infections and complex cases, this approach delivers:
✔️ Faster answers
✔️ Better treatment decisions
✔️ Improved patient satisfaction

✨ Stay ahead with Seegene’s respiratory diagnostic solutions!